Clinical Trials on Solid and Hematological Malignancies
Total 18248 results
-
University Hospital TuebingenActive, not recruitingSolid Tumor | Influenza | SARS-CoV-2 | Hematologic MalignancyGermany
-
Izmir Bakircay UniversityCompletedHematological Malignancy | Bone Marrow DiseaseTurkey
-
Zai Lab (Shanghai) Co., Ltd.Completed
-
BioMed Valley Discoveries, IncTerminatedSolid Tumor MalignanciesUnited States
-
Royal Marsden NHS Foundation TrustInstitute of Cancer Research, United KingdomUnknownAdvanced Solid MalignanciesUnited Kingdom
-
Johnson & Johnson Pharmaceutical Research & Development...Janssen Pharmaceutica N.V., BelgiumCompletedPharmacokinetics | Advanced Malignancies | Solid Malignancies | Protein Kinase Inhibitors | Maximum Tolerated Dose | Antineoplastic Protocols | Clinical Trial, Phase 1
-
Fondazione EMN Italy OnlusCompletedHEMATOLOGIC MALIGNANCIESItaly
-
Sohag UniversityNot yet recruiting
-
IncuronTerminatedHematological MalignanciesUnited States
-
Gemin XCompletedHematological MalignanciesUnited States, Canada
-
Nanfang Hospital of Southern Medical UniversityUnknownAntibacterial Prophylaxis vs no Prophylaxis for Hematological Malignancies Patients Before Allo-HSCTHematological Malignancies | Imipenem | Antibacterial Prophylaxis | Allogenetic Hematopoietic Stem Cell TransplantationChina
-
Centre Hospitalier Régional Metz-ThionvilleUniversity of LorraineRecruitingAnxiety | Hematological Malignancies | Relaxation | Adapted Physical ActivityFrance
-
Karyopharm Therapeutics IncCompletedHematological MalignanciesUnited States, Denmark, Canada
-
Anthony Sung, MDMassachusetts General HospitalCompleted
-
University of Michigan Rogel Cancer CenterOtsuka Pharmaceutical Development & Commercialization, Inc.Completed
-
Ankara UniversityThe Scientific and Technological Research Council of TurkeyCompletedHematopoietic Stem Cell TransplantationTurkey
-
Washington University School of MedicineRecruitingPediatric Hematologic MalignanciesUnited States
-
Cancer Research UKRoyal Marsden NHS Foundation Trust; Hoffmann-La Roche; University of Manchester; University of BirminghamRecruitingGlioma | Melanoma | Neoplasms by Histologic Type | Lymphoproliferative Disorders | Neoplasms by Site | Cancer | Brain Neoplasms | Solid Tumor | Malignant Neoplasm | Malignancy | Haematological MalignancyUnited Kingdom
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Recruiting
-
Tampere University HospitalHelsinki University Central Hospital; Tampere University; University of Eastern... and other collaboratorsActive, not recruiting
-
Aaron Cumpston, PharmD, BCOPCompletedNeutropenia | Hematological MalignancyUnited States
-
Hospices Civils de LyonUnknown
-
Astellas Pharma IncCompletedLocally Advanced (Unresectable) or Metastatic Solid Tumor MalignanciesJapan
-
Sinocelltech Ltd.RecruitingRelapsed or Refractory Hematologic MalignanciesChina
-
Vanda PharmaceuticalsUnknownRelapsed or Refractory Hematologic MalignanciesUnited States
-
Precision BioSciences, Inc.RecruitingHematologic Malignancy | CD19 Expressing MalignanciesUnited States
-
AGC Biologics S.p.A.CompletedHematological MalignanciesItaly, Israel, United Kingdom, Germany, Greece
-
AstraZenecaCompletedAdvanced Solid MalignanciesUnited States, Germany, Italy, United Kingdom, Canada, France, Korea, Republic of, Netherlands
-
Kai Lin Xu; Jun Nian ZhengiCarTAB BioMed Inc.UnknownRecurrent or Refractory B Cell MalignancyChina
-
University of UtahTerminatedHigh Risk Hematologic MalignanciesUnited States
-
King Faisal Specialist Hospital & Research CenterCompletedTransplantation for Hematologic MalignanciesSaudi Arabia
-
Rennes University HospitalWithdrawn
-
Zhejiang UniversityYake Biotechnology Ltd.RecruitingCD7+ Acute Leukemia | CD7+ LymphomaChina
-
M.D. Anderson Cancer CenterImmunoGen, Inc.Completed
-
Imperial College LondonWithdrawnAllogeneic Stem Cell Transplant | Haematological Malignancies | CD56+CD3- NK CellsUnited Kingdom
-
S*BIOCompletedMyelodysplastic Syndrome | Solid Tumors | Hematologic MalignanciesUnited States, Singapore
-
The University of Hong KongRecruitingCancer | Graft Vs Host Disease | Haematological MalignancyHong Kong
-
Nantes University HospitalFor Ever FabienRecruitingChild, Only | Hematologic Malignancy | Hematologic Non Malignancy | Solid Tumor, ChildhoodFrance
-
Hangzhou Sumgen Biotech Co., Ltd.RecruitingSG2501 Safety Study in Subjects With Relapsed or Refractory Hematological Malignancies and Lymphoma.Lymphoma | Hematological MalignancyUnited States
-
PersonGen BioTherapeutics (Suzhou) Co., Ltd.Peking University People's Hospital; The First Affiliated Hospital of Zhengzhou... and other collaboratorsRecruitingCD7-positive Relapsed/Refractory Lymphoid Hematologic MalignanciesChina
-
Baylor College of MedicineThe Methodist Hospital Research Institute; Center for Cell and Gene Therapy...CompletedHematologic MalignancyUnited States
-
BioMed Valley Discoveries, IncCompletedSolid Tumor MalignanciesUnited States
-
University College, LondonMedical Research CouncilCompletedHaematological MalignanciesUnited Kingdom
-
M.D. Anderson Cancer CenterICN PharmaceuticalsCompletedHematological MalignanciesUnited States
-
Anand B. KarnadCompletedAdvanced B-cell Lymphoid MalignanciesUnited States
-
Assistance Publique - Hôpitaux de ParisRecruitingSolid Tumor | Thoracic Cancer | Hematologic Malignancy | Cancer, Treatment-Related | Vaccine Response ImpairedFrance
-
H. Lee Moffitt Cancer Center and Research InstituteCancer and Aging Research GroupRecruitingLymphoma | Leukemia | MyelomaUnited States
-
Affiliated Hospital to Academy of Military Medical...Beijing JD Biotech Co. LTD.RecruitingAdult Relapsed/Refractory B-cell Hematologic MalignanciesChina
-
University of Illinois at ChicagoRecruitingRelapsed or Refractory Hematologic MalignanciesUnited States
-
Sunshine Lake Pharma Co., Ltd.Active, not recruitingRelapsed or Refractory B-cell Hematologic MalignanciesChina